These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 677971

  • 1. Influence of MAO-inhibitors on deamination of 3H-norepinephrine in the dog's saphenous vein.
    Verbeuren TJ, Vanhoutte PM.
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):348-9. PubMed ID: 677971
    [No Abstract] [Full Text] [Related]

  • 2. Role of neuronal uptake in the disposition of released [3H]-noradrenaline in the dog's saphenous vein [proceedings].
    Vanhoutte PM, Verbeuren TJ.
    Br J Pharmacol; 1979 May; 66(1):149P. PubMed ID: 454941
    [No Abstract] [Full Text] [Related]

  • 3. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM, Osswald W.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [Abstract] [Full Text] [Related]

  • 4. Deamination of released 3H-noradrenaline in the canine saphenous vein.
    Verbeuren TJ, Vanhoutte PM.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.
    Caramona MM.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):121-4. PubMed ID: 7110373
    [Abstract] [Full Text] [Related]

  • 6. The role of monoamine oxidase in the metabolism of exogenous noradrenaline by the human saphenous vein.
    Branco D, Caramona M, Araújo D, Osswald W.
    Fundam Clin Pharmacol; 1992 May; 6(3):145-52. PubMed ID: 1628876
    [Abstract] [Full Text] [Related]

  • 7. The effect of labetalol on the release of [3H]-labelled noradrenaline and its metabolites from dog isolated saphenous vein [proceedings].
    Drew GM, Levy GP, Sullivan AT.
    Br J Pharmacol; 1979 May; 66(1):151P. PubMed ID: 454943
    [No Abstract] [Full Text] [Related]

  • 8. Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.
    Caramona MM, Araújo D, Brandão F.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):401-6. PubMed ID: 3921856
    [Abstract] [Full Text] [Related]

  • 9. Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein.
    Caramona MM, Esplugues JV, Osswald W.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):181-5. PubMed ID: 2935741
    [Abstract] [Full Text] [Related]

  • 10. Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.
    Westwood NN, Bryan-Lluka LJ.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):815-21. PubMed ID: 8246156
    [Abstract] [Full Text] [Related]

  • 11. Oxidative deamination of noradrenaline in human blood vessels.
    Osswald W.
    J Neural Transm Suppl; 1990 Nov; 32():395-404. PubMed ID: 2089103
    [Abstract] [Full Text] [Related]

  • 12. The effect of monoamine oxidase and catechol O-methyltransferase inhibitors on the accumulation and metabolism of [l-3H] norepinephrine by the adventitia and media of rabbit aorta.
    Levin JA, Wilson SE.
    J Pharmacol Exp Ther; 1977 Dec; 203(3):598-609. PubMed ID: 925961
    [Abstract] [Full Text] [Related]

  • 13. Influence of neuronal uptake inhibitors on tissue accumulation of 3H-norepinephrine and its metabolites in isolated canine saphenous veins.
    Verbeuren TJ, Coen EP, Vanhoutte PM.
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):314-5. PubMed ID: 7165439
    [No Abstract] [Full Text] [Related]

  • 14. Halothane-induced changes in the release and disposition of norepinephrine at adrenergic nerve endings in dog saphenous vein.
    Lunn JJ, Rorie DK.
    Anesthesiology; 1984 Oct; 61(4):377-84. PubMed ID: 6486500
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of MAO inhibitors on uptake and release of norepinephrine in rat brain in vitro.
    Ziance RJ, Moxley K, Mullis M, Gray W.
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):30-8. PubMed ID: 921400
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The endothelium inhibits the penetration of serotonin and norepinephrine in the isolated canine saphenous vein.
    Verbeuren TJ, Jordaens FH, Bult H, Herman AG.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):276-82. PubMed ID: 3336004
    [Abstract] [Full Text] [Related]

  • 20. Effect of cooling on efflux of [3H]-noradrenaline in canine cutaneous veins [proceedings].
    Janssens WJ, Vanhoutte PM.
    Br J Pharmacol; 1979 May; 66(1):148P. PubMed ID: 454940
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.